Roche Holding AG (RHHBY)
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium. Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies. These target a broad spectrum of medical fields, including oncology, neuroscience, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments. The comprehensive product line further extends to treatments for specific conditions like infectious diseases, anemia, various dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation-related needs. Within its diagnostics segment, Roche develops and markets a wide variety of laboratory-based tests designed to identify and monitor numerous illnesses. These include, but are not limited to, cancer, diabetes, Covid-19, hepatitis, and human papillomavirus. Additionally, the company is a provider of essential diagnostic instruments and reagents. Established in 1896, Roche Holding AG maintains its corporate headquarters in Basel, Switzerland.
Sector: Drug Manufacturers - General
Industry: Drug Manufacturers - General
Roche Holding AG
- 0.5%
- 2.9M
- 1.00
Float 646.17M · FMP free float
The cost to borrow RHHBY shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 6.4%
- 9
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 2.9M sh |
| Oct 15, 2026 | 2.7M sh |
| Sep 30, 2026 | 3.0M sh |
| Sep 15, 2026 | 2.4M sh |
| Aug 31, 2026 | 3.0M sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Oct 30, 2026 | 9 sh |
| Oct 29, 2026 | 148 sh |
| Oct 27, 2026 | 196 sh |
| Oct 26, 2026 | 4.6K sh |
| Oct 22, 2026 | 1.9K sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Latest sessions
| Date | Reported short |
|---|---|
| Nov 17, 2026 | 6.4% |
| Nov 16, 2026 | 43.4% |
| Nov 13, 2026 | 31.3% |
| Nov 12, 2026 | 31.2% |
| Nov 11, 2026 | 25.6% |
130 calendar days requested; 92 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.
Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
FINRA's weekly alternative trading system (dark pool) volume for RHHBY: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 2,892,550 RHHBY shares were sold short (0.45% of a 646.17M-share float, 1.00 days to cover).